Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perioperative procoagulant strategies combined with rivaroxaban in arthroplasty
ChiCTR-TRC-14004379Phase 4Completed
- Sponsor
- Fujian Provincial Hospital
- Start
- Apr 2014
- Modality
- Small Molecules, Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label trial of hemocoagulase, tranexamic acid and rivaroxaban in perioperative bleeding and venous thromboembolism (VTE) (3 arms), sponsored by Fujian Provincial Hospital. Primary endpoints: Drainage volume, Blood transfusion and 6 more. Started Apr 2014; status: completed.
02
Drugs
hemocoagulasetranexamic acidrivaroxaban
03
Conditions
perioperative bleedingvenous thromboembolism (VTE)
Beyond the preview
Go deeper on ChiCTR-TRC-14004379.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-14004379.